About DongKook Pharma
DongKook Pharma is a publicly listed company based in Seoul (South Korea) founded in 1968. Pharmaceutical products are manufactured and distributed globally by DongKook Pharma. The company has 1,220 employees. Its website dkpharm.co.kr draws about 130 thousand monthly visits. DongKook Pharma offers products and services including FeraminQ and Centellian24 Madeca Prime. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Dongkook Pharmaceutical Co., Ltd.
Company details
DongKook Pharma was established in 1968 in Seoul, South Korea, within the pharmaceutical sector. Operations involve the production and distribution of over-the-counter and prescription medications, alongside healthcare items. Research and development activities are directed toward innovative treatments for unmet medical needs. Products are exported to various international markets. Emphasis is placed on upholding rigorous manufacturing and quality control protocols.
- Headquarters Seoul, South Korea
- Employees 1,220
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website dkpharm.co.kr
- Social YouTube
- Legal Name Dongkook Pharmaceutical Co., Ltd.
- Annual Revenue$641.79 M (USD)14.12as on Dec 31, 2025
- Net Profit$45.71 M (USD)7.84as on Dec 31, 2025
- EBITDA$88.61 M (USD)18.34as on Dec 31, 2025
- Employee Count1,220
Products & Services of DongKook Pharma
DongKook Pharma offers a comprehensive portfolio of products and services, including FeraminQ and Centellian24 Madeca Prime.
A treatment for women's menopause symptoms is provided through this product
Skincare products using natural extracts are offered for beauty and health enhancement
Apps and channels of DongKook Pharma
its YouTube channel 동국제약 has 17.9K subscribers and 30 videos.
Videos from DongKook Pharma
The most watched videos on DongKook Pharma's YouTube channel, 동국제약 (17.9K subscribers). Click a video to play it here.
More on 동국제약.
IPO & Listings of DongKook Pharma
DongKook Pharma is a publicly listed company on the KRX with ticker symbol 086450 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date29 May 2007
- Listed onKRX: 86450
- Listed entityDongKook Pharmaceutical Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7086450004
- Share price24,250.00 KRW (+4.3% on the day) · 2026-10-14
- Market capitalisation1,040,175,682,068.00 KRW
- Price to earnings14.3
- EPS (diluted, trailing year)1,698.01 KRW
- Dividend yield0.86%
- Volume (last session)860,265
Financials of DongKook Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 926.88B KRW | 66.02B KRW | 127.97B KRW |
| 2024 | 812.17B KRW | 61.22B KRW | 108.14B KRW |
| 2023 | 730.99B KRW | 47.18B KRW | 87.96B KRW |
| 2022 | 661.65B KRW | 52.90B KRW | 91.43B KRW |
| 2021 | 594.19B KRW | 50.35B KRW | 80.57B KRW |
Detailed financial statements for DongKook Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of DongKook Pharma
The website of DongKook Pharma (dkpharm.co.kr) receives about 129.6K visits a month and ranks #211,864 among all websites worldwide, #6,928 in Biotechnology and Pharmaceuticals.
- Monthly visits129.6K
▼ 2.6% vs previous month
- Unique visitors27.3K
per month
- Global rank#211,864
among all websites
- Category rank#6,928
Health · Biotechnology and Pharmaceuticals
- Bounce rate21%
- Pages per visit8.8
- Average visit15 min 58 sec
- DevicesDesktop 66% ยท Mobile 34%
Websites whose visitors overlap most with DongKook Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hanlim.com | 100% | #1,972,513 | View details | ||
edkshop.com | edkshop.com | 86% | #140,880 | โ | |
healthcare.joins.com | healthcare.joins.com | 76% | โ | ||
| health.kr | 70% | #14,868 | View details | ||
yuantzecentre.co.nz | yuantzecentre.co.nz | 62% | โ | ||
| โขโขโขโขโขโขโขโขโขโข | โขโขโขโขโขโข.com | โขโข% | โข.โขM | #โขโขโขโขโข | โ |
| โขโขโขโขโขโขโขโขโขโข | โขโขโขโขโขโข.com | โขโข% | โข.โขM | #โขโขโขโขโข | โ |
| โขโขโขโขโขโขโขโขโขโข | โขโขโขโขโขโข.com | โขโข% | โข.โขM | #โขโขโขโขโข | โ |
All 21 similar websites and full traffic analytics for DongKook Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track โ from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dongkook Pharma
Complete news archive for DongKook Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DongKook Pharma
DongKook Pharma was founded in 1968.
DongKook Pharma is headquartered in Seoul, South Korea.
DongKook Pharma has 1,220 employees.
Annual revenue of DongKook Pharma is $641.79M as on Dec 31, 2025.
DongKook Pharma was established in 1968 in Seoul, South Korea, within the pharmaceutical sector. Operations involve the production and distribution of over-the-counter and prescription medications, alongside healthcare items. Research and development activities are directed toward innovative treatments for unmet medical needs. Products are exported to various international markets. Emphasis is placed on upholding rigorous manufacturing and quality control protocols.
DongKook Pharma offers FeraminQ and Centellian24 Madeca Prime.
Yes, DongKook Pharma is publicly traded on KRX under the ticker symbol 086450.
DongKook Pharma operates through Dongkook Pharmaceutical Co., Ltd..
The website of DongKook Pharma receives about 130 thousand visits a month and ranks #211,864 among all websites worldwide.